Case Report: Pituitary Morphology and Function Are Preserved in Female Patients With Idiopathic Intracranial Hypertension Under Pharmacological Treatment.
IIH
empty sella
growth hormone
obesity
pituitary MRI
pituitary hormones
prolactin
pseudotumor cerebri
Journal
Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782
Informations de publication
Date de publication:
2020
2020
Historique:
received:
01
10
2020
accepted:
23
11
2020
entrez:
25
1
2021
pubmed:
26
1
2021
medline:
28
5
2021
Statut:
epublish
Résumé
Idiopathic Intracranial Hypertension is a neurological disorder primarily affecting overweight women of childbearing age. It is often characterized by radiologic evidence of empty sella (ES), which is in turn frequently associated with pituitary dysfunction, with the somatotropic axis most commonly affected. No recent evidence is available relative to the presence of pituitary hormone deficiencies in adult patients with Idiopathic Intracranial Hypertension (IIH) under pharmacological therapy. We therefore explored pituitary function and morphology in a small cohort of female patients with IIH treated with acetazolamide. Fifteen female patients aged 42 ± 13 years with IIH lasting between 12 and 18 months were evaluated. All patients were affected by recurrent headaches in addition to visual changes of variable severity. IIH diagnosis was made after exclusion of other causes of raised intracranial pressure, and a specific ophthalmological evaluation was conducted to assess for the presence of papilledema. No particular endocrinological disturbances were detected during the enrolment visits, except for a high obesity prevalence (87%, BMI 35.16 ± 8.21 kg/m
Identifiants
pubmed: 33488525
doi: 10.3389/fendo.2020.613054
pmc: PMC7819854
doi:
Substances chimiques
Diuretics
0
Acetazolamide
O3FX965V0I
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
613054Informations de copyright
Copyright © 2021 Tozzi, Moramarco, Watanabe, Balena, Caputi, Gangitano, Petrangeli, Mariani, Gnessi and Lubrano.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Neurol Neurosurg Psychiatry. 1981 Aug;44(8):731-4
pubmed: 6795313
Neuroophthalmology. 2016 May 27;40(4):165-170
pubmed: 27928402
Neuroradiology. 2013 Aug;55(8):955-961
pubmed: 23708942
J Neurosurg. 2005 Nov;103(5):831-6
pubmed: 16304986
J Neuroophthalmol. 2019 Sep;39(3):324-329
pubmed: 31430269
Eur J Pediatr. 1997 Jan;156(1):69-70
pubmed: 9007496
PLoS One. 2018 Aug 28;13(8):e0202683
pubmed: 30153310
Neurology. 2002 Nov 26;59(10):1492-5
pubmed: 12455560
J Clin Endocrinol Metab. 1996 Aug;81(8):3103-11
pubmed: 8768882
Dtsch Arztebl Int. 2018 Feb 16;115(7):99-105
pubmed: 29510819
Cephalalgia. 2013 Oct;33(13):1075-84
pubmed: 23615489
Eat Weight Disord. 2020 May 25;:
pubmed: 32451949
Endocrine. 2015 Jun;49(2):503-11
pubmed: 25614038
Endocr Res. 2001 Aug;27(3):303-7
pubmed: 11678577
Curr Eye Res. 2013 Sep;38(9):972-6
pubmed: 23713489
Arch Neurol. 1986 Sep;43(9):902-6
pubmed: 3090985
J Endocrinol Invest. 2002 Apr;25(4):329-33
pubmed: 12030603
Pediatr Endocrinol Rev. 2006 Dec;3 Suppl 4:576-8
pubmed: 17237746
J Med Case Rep. 2013 May 31;7:149
pubmed: 23725039
Eur J Ophthalmol. 2004 Jan-Feb;14(1):48-54
pubmed: 15005585
J Clin Endocrinol Metab. 2005 Sep;90(9):5471-7
pubmed: 15972577
AJNR Am J Neuroradiol. 1996 Nov-Dec;17(10):1953-6
pubmed: 8933886
Cephalalgia. 2019 Feb;39(2):245-253
pubmed: 29911422
Curr Neurol Neurosci Rep. 2018 May 2;18(6):33
pubmed: 29721718
J Endocrinol Invest. 2010 May;33(5):343-6
pubmed: 20208457
AJNR Am J Neuroradiol. 2001 Jan;22(1):196-9
pubmed: 11158909
Acta Endocrinol (Copenh). 1976 Nov;83(3):483-92
pubmed: 989992
J Neurol. 2011 Nov;258(11):2014-9
pubmed: 21523461
AJNR Am J Neuroradiol. 2011 Dec;32(11):1986-93
pubmed: 21680652
Eur J Endocrinol. 2017 Dec;177(6):R275-R285
pubmed: 28780516